Dassault Systemes Stock Price, News & Analysis

Dassault Systèmes reported robust third-quarter 2021 results, with total revenue soaring 12% to €1.16 billion. Diluted EPS increased 94% to €0.14, while non-IFRS EPS grew 40% to €0.22. Strong performance was particularly noted in Licenses and other software revenue, which rose 24%. The company raised its full-year guidance, projecting revenue growth of 10%-11% and EPS growth of 25%-27%. Operating margin improved to 33.8%, up from 28.2% year-on-year. Cash flow from operations increased by 24.5% to €1.25 billion, reflecting strong business momentum across various industries.

Dassault Systèmes will announce its operating performance for Q3 2021 on October 28, 2021. The webcast starts at 10:00 AM Paris time and a conference call follows at 9:00 AM New York time. Both events will be accessible live and archived on Dassault Systèmes’ investor website. The company, a leader in 3D design and PLM solutions, serves over 290,000 customers globally. With 20,000 employees across more than 140 countries, Dassault Systèmes continues to foster innovation through its 3DEXPERIENCE platform.

Tarek Sherif, co-founder of Medidata and Life Sciences & Healthcare Sector Board Chairman for Dassault Systemes, joins the board of directors at Florence. With over 20 years of experience, including leading Medidata to an IPO and acquiring it for $5.8B, Sherif aims to enhance Florence's position in clinical research. The company, serving over 10,000 trial sites in 44 countries, recently raised $80M in a Series C funding round to improve trial site efficiencies and connectivity in clinical development.

Dassault Systèmes has announced a global employee shareholding program targeting around 98% of its workforce. This capital increase will involve issuing up to 5 million shares on January 20, 2022. Through this initiative, employees will participate more closely in the company's growth and benefit from their contributions. CEO Bernard Charlès emphasized the program's inclusive approach and long-term vision, underscoring the importance of employee investment in the company's journey.

Dassault Systèmes disclosed its trading activity in its own shares for the period from September 30 to October 1, 2021. During this time, a total of 278,513 shares were traded at a weighted average price of €45.6740 on XPAR. Additionally, on October 1, 2021, 354,000 shares were traded at an average price of €44.9420. This trading is in line with the share repurchase program authorized by the General Meeting of Shareholders on May 26, 2021. Detailed information can be accessed on Dassault Systèmes' investor relations website.

Dassault Systèmes has reported the number of outstanding shares and voting rights as of September 30, 2021. The total number of outstanding shares is 1,331,754,937, while the total voting rights amount to 1,992,397,166. This information is in compliance with the regulations set by the Autorité des marchés financiers. Shareholders are advised to refer to Article 223-11 for details on declaring thresholds. For declarations related to crossing thresholds, shareholders can contact the Investors Relations Service of Dassault Systèmes.

Dassault Systèmes SE has disclosed its trading activities for the period from September 24 to September 29, 2021, following the repurchase program approved by shareholders on May 26, 2021. During this time, a total of 1,400,384 shares were repurchased, with daily volumes ranging from 15,890 to 331,346 shares. The average acquisition prices varied each day, with the lowest being approximately 45.91 and the highest at 49.50 per share. Full details about the transactions can be found on their investor relations website.

AllStripes has appointed Sherwin Chen as Chief Legal Officer and Joe Walsh as Vice President, Head of Commercial. These appointments are aimed at supporting the company's growth in rare disease research. Chen brings nearly 20 years of legal expertise from roles at Color Health and Roche, while Walsh has significant experience from Komodo Health. Both leaders will enhance AllStripes' efforts to empower the rare disease community and expand partnerships within the life sciences sector.

Dassault Systèmes disclosed the trading activities for its own shares from September 16 to September 22, 2021, as part of the repurchase program approved by shareholders on May 26, 2021. During this period, the company reported numerous transactions across various markets, including XPAR and DXE. The total volume of shares traded varied daily with acquisition prices averaging approximately €49.49. Detailed information on these transactions is available on the company's investor relations website.